Viewing Study NCT06636474



Ignite Creation Date: 2024-10-26 @ 3:42 PM
Last Modification Date: 2024-10-26 @ 3:42 PM
Study NCT ID: NCT06636474
Status: RECRUITING
Last Update Posted: None
First Post: 2024-09-27

Brief Title: Evaluation of the Supported Housing System for the Inclusion of People Suffering From Mental Disorders
Sponsor: None
Organization: None

Study Overview

Official Title: Evaluation of the Supported Housing System for the Inclusion of People Suffering From Mental Disorders
Status: RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: EVA-DLAI
Brief Summary: Access to housing in the current context of extreme tension in the rental housing market in Paris and throughout the Ile-de-France region is proving to be extremely complex for people with mental health problemsNational and international scientific studies have quantified the problem of homelessness and precarious or inappropriate housing among patients suffering from psychiatric disorders and show the impact of housing problems on the consumption of psychiatric careThe DÉLAIs mission is to facilitate access to housing for people enrolled in a psychiatric care pathway with teams from the psychiatric sectors
Detailed Description: Written and oral information provided to the patient by the patients referring psychiatrist Investigator of one of the five recruiting sites during a regular consultation appointment
Initial assessment V inclusion reminder of the information concerning the research collection of consent collection of sociodemographic data and standardized assessment scales quality of life clinical state level of functioning standardized semi-structured interview for the diagnosis of psychiatric disorders completion by the referring psychiatrist of the data corresponding to the patients care pathway
Then follow-up visit at an annual rate V1 VX and DLAI exit assessment V exit as soon as the patient stops benefiting from the DLAI

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None